NDAORALTABLET, EXTENDED RELEASE
Approved
Mar 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
CHLOR-TRIMETON (chlorpheniramine maleate; pseudoephedrine sulfate) by Bayer. Approved for these symptoms due to hay fever, other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose and 1 more indications. First approved in 1981.
Drug data last refreshed 6h ago · AI intelligence enriched 8h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Chlor-Trimeton is a fixed-dose combination oral tablet containing chlorpheniramine maleate (first-generation antihistamine) and pseudoephedrine sulfate (nasal decongestant) approved in 1981. It treats symptoms of hay fever and upper respiratory allergies including runny nose, itchy/watery eyes, sneezing, and throat itching. The antihistamine blocks histamine receptors to reduce allergic symptoms while the decongestant causes vasoconstriction to relieve nasal congestion.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating declining team focus and reduced headcount expansion opportunities in commercial roles.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on CHLOR-TRIMETON at Bayer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.